Skip to content

Tomosynthesis Use in Detecting Subtle Occult Hip Fractures

Tomosynthesis Use in Detecting Subtle Occult Hip Fractures

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02133794
Enrollment
60
Registered
2014-05-08
Start date
2014-06-30
Completion date
2014-12-31
Last updated
2014-05-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hip Fracture

Keywords

Hip fracture, Tomosynthesis, X-ray, Emergency room

Brief summary

The purpose of this project is to determine if using tomosynthesis, in conjunction with x-ray, is better at detecting hip fractures than using x-ray alone. The goal of this study will be to include the use of tomosynthesis with x-ray as usual practice when a patient comes to the emergency room with symptoms of a hip fracture.

Interventions

Sponsors

Medical Imaging Informatics Research Centre at McMaster
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum

Inclusion criteria

* Men and women aged \> 18 years who/se: * Present at the ER with a possible hip fracture and * Have a negative x-ray for a hip fracture * Physician has a high clinical suspicion of a hip fracture * Provide provision of informed consent

Exclusion criteria

* Hip prosthesis on the same side of the suspected hip fracture * Other serious medical illness that is likely to interfere with study participation * Significant psychiatric illness, senility, dementia, alcohol or substance abuse, which could impair the ability to provide informed consent and to adhere to the trial procedures * Pregnant or suspected pregnancy

Design outcomes

Primary

MeasureTime frame
Number of patients with hip fracture detected with tomosynthesis versus x-ray alone.Participants will be followed up to 3 months post tomosynthesis exam.

Secondary

MeasureTime frame
ER wait timeEnd of study

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026